161 related articles for article (PubMed ID: 20180482)
21. Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database.
Pokharel Y; Akeroyd JM; Ramsey DJ; Hira RS; Nambi V; Shah T; Woodard LD; Winchester DE; Ballantyne CM; Petersen LA; Virani SS
Clin Cardiol; 2016 Apr; 39(4):185-91. PubMed ID: 27059708
[TBL] [Abstract][Full Text] [Related]
22. Concordance between psychotropic prescribing for veterans with PTSD and clinical practice guidelines.
Jain S; Greenbaum MA; Rosen C
Psychiatr Serv; 2012 Feb; 63(2):154-60. PubMed ID: 22302333
[TBL] [Abstract][Full Text] [Related]
23. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
24. Underuse of cardioprotective medications in patients prior to acute myocardial infarction.
Miller RR; Li YF; Sun H; Kopjar B; Sales AE; Piñeros SL; Fihn SD
Am J Cardiol; 2003 Jul; 92(2):209-11. PubMed ID: 12860227
[No Abstract] [Full Text] [Related]
25. Physician process and patient outcome measures for diabetes care: relationships to organizational characteristics.
Ward MM; Yankey JW; Vaughn TE; BootsMiller BJ; Flach SD; Welke KF; Pendergast JF; Perlin J; Doebbeling BN
Med Care; 2004 Sep; 42(9):840-50. PubMed ID: 15319609
[TBL] [Abstract][Full Text] [Related]
26. Why are statin prescribing guidelines for primary prevention not always followed in primary care?
Hassan Y; Ford J; Steel N; Sheldon J; Fleetcroft R
Br J Gen Pract; 2016 Oct; 66(651):536-7. PubMed ID: 27688515
[No Abstract] [Full Text] [Related]
27. Racial differences in compliance with NCEP-II recommendations for secondary prevention at a Veterans Affairs medical center.
Williams ML; Morris MT; Ahmad U; Yousseff M; Li W; Ertel N;
Ethn Dis; 2002; 12(1):S1-58-62. PubMed ID: 11913623
[TBL] [Abstract][Full Text] [Related]
28. Comparison of characteristics of patients with coronary heart disease receiving lipid-lowering therapy versus those not receiving such therapy.
Kopjar B; Sales AE; Piñeros SL; Sun H; Li YF; Hedeen AN
Am J Cardiol; 2003 Jun; 91(11):1352-4. PubMed ID: 12767433
[No Abstract] [Full Text] [Related]
29. Assessment of lipid-lowering treatment in France--the CEPHEUS study.
Ferrières J; Gousse ET; Fabry C; Hermans MP;
Arch Cardiovasc Dis; 2008 Sep; 101(9):557-63. PubMed ID: 19041840
[TBL] [Abstract][Full Text] [Related]
30. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study.
Cordero A; Rodriguez Padial L; Batalla A; López Barreiro L; Torres Calvo F; Castellano JM; Ruiz E; Bertomeu-Martínez V;
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957818
[TBL] [Abstract][Full Text] [Related]
31. Adherence to the U.S. Preventive Services Task Force 2002 osteoporosis screening guidelines in academic primary care settings.
Powell H; O'Connor K; Greenberg D
J Womens Health (Larchmt); 2012 Jan; 21(1):50-3. PubMed ID: 22150154
[TBL] [Abstract][Full Text] [Related]
32. Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.
McBride CL; Akeroyd JM; Ramsey DJ; Nambi V; Nasir K; Michos ED; Bush RL; Jneid H; Morris PB; Bittner VA; Ballantyne CM; Petersen LA; Virani SS
Vasc Med; 2018 Jun; 23(3):232-240. PubMed ID: 29600737
[TBL] [Abstract][Full Text] [Related]
33. Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
Hwang EW; Thomas IC; Cheung R; Backus LI
J Clin Gastroenterol; 2013 Mar; 47(3):264-70. PubMed ID: 23269309
[TBL] [Abstract][Full Text] [Related]
34. Pharmacoeconomic impact evaluation of statin adherence in high-risk unselected post myocardial infarction population: an administrative database-guided analysis.
Summaria F; Ciaralli F; Mustilli M; Sette A; Lanzillo C; Vasselli L
Med Arch; 2013; 67(5):314-7. PubMed ID: 24601159
[TBL] [Abstract][Full Text] [Related]
35. Miracle or mirage?
Learner S
Nurs Stand; 2007 Aug 1-7; 21(47):18-20. PubMed ID: 17824448
[TBL] [Abstract][Full Text] [Related]
36. Predictors, barriers, and facilitators of lipid-lowering medication use among African Americans in a primary care clinic.
Schwartz KL; Dailey R; Bartoces M; Binienda J; Archer C; Neale AV
J Natl Med Assoc; 2009 Sep; 101(9):944-52. PubMed ID: 19806853
[TBL] [Abstract][Full Text] [Related]
37. Relationship of Provider and Practice Volume to Performance Measure Adherence for Coronary Artery Disease, Heart Failure, and Atrial Fibrillation: Results From the National Cardiovascular Data Registry.
Fleming LM; Jones P; Chan PS; Andrei AC; Maddox TM; Farmer SA
Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):48-54. PubMed ID: 26646817
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
39. Secondary prevention for coronary artery disease: are we following the guidelines?
Syed IA; Riaz A; Ryan A; Reilly MO
Ir J Med Sci; 2010 Dec; 179(4):535-7. PubMed ID: 20676796
[TBL] [Abstract][Full Text] [Related]
40. Variations in lipid screening frequency in family medicine patients with cardiovascular risk factors.
Doganer YC; Rohrer JE; Angstman KB; Merry SP; Erickson JL
J Eval Clin Pract; 2015 Apr; 21(2):215-20. PubMed ID: 25394299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
